Buy! Sell! Puff, Puff, Pass! – Wall Street Drops Drug Testing for Cannabis, What It Could Mean for Your 401k

This trend among Wall Street institutions reflects a broader reevaluation of cannabis nationwide, influenced by its legal status in multiple U.S. states and evolving public sentiment. The shift is driven in part by practical considerations, such as the difficulty of enforcing stringent drug-free policies in areas where cannabis is legal and the necessity of attracting top talent in a competitive job market.